TokenPost topic

IMVT-1402

1 TokenPost story is tagged IMVT-1402. The newest appear first.

Latest IMVT-1402 stories

• Roivant Highlights IMVT-1402 for 85,000 Difficult-to-Treat RA Patients

  Roivant estimates 85,000 people have difficult-to-treat RA. At Week 28, 92.5% of the 600-milligram group maintained an ACR20 response, compared with about 75% on placebo.

  Nov 10, 2026, 5:46 PM EST · Business